Dogwood Therapeutics, Inc. (DWTX)

Dogwood Therapeutics, Inc. (DWTX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $42.5M; returns 1 day +0.0%, 1 week -8.2%, 1 year -80.1%.

Dogwood Therapeutics, Inc. (formerly Virios Therapeutics, Inc., renamed in October 2024) is a development-stage biotechnology company focused on discovering and developing novel non-opioid medicines to treat chronic pain, fatigue-related disorders, and neuropathy.

Groups DWTX belongs to

• Biotechnology
• Healthcare
• Biopharmaceutical
• Clinical Stage
• Clinical Stage Biotech
• Clinical Stage Biopharma
• Pain Management
• Life Sciences
• Drug Discovery
• Fast Track Designation

DWTX financial model: income statement, cash flow and balance sheet